Location History:
- Bridgewater, NJ (US) (2019)
- Teaneck, NJ (US) (2003 - 2021)
Company Filing History:
17 out of 2,405 
6 out of 4,770 
1 out of 216 
Years Active: 2003-2021
Title: Innovations by Subharekha Raghavan: A Pioneer in Pharmaceutical Patents
Introduction
Subharekha Raghavan is an esteemed inventor based in Teaneck, New Jersey, holding a remarkable 23 patents to his name. His groundbreaking work primarily focuses on the development of novel therapeutic agents, particularly in the realm of pharmacology. With a commitment to addressing various medical disorders, Raghavan's innovations reflect a dedication to improving human health through scientific advancements.
Latest Patents
Among his most recent contributions are patents related to substituted pyrazolo[3,4-d]pyrimidines as phosphodiesterase 9 (PDE9) inhibitors. These pyrazolopyrimidine compounds, characterized by their unique structural formula, have significant potential as therapeutic agents in treating disorders related to PDE9. Specific applications of these compounds include the treatment of cardiovascular diseases such as hypertension, chronic kidney disease, and heart failure. Moreover, Raghavan's inventions also target neurological and psychiatric disorders, including schizophrenia, psychosis, and Huntington's disease, particularly those associated with striatal hypofunction or basal ganglia dysfunction.
Career Highlights
Throughout his career, Subharekha Raghavan has contributed to leading pharmaceutical companies, including Merck Sharp & Dohme Corporation and Merck & Company, Inc. His expertise in drug development has been instrumental in advancing innovative therapeutic solutions within the industry. Raghavan's prolific output of patents showcases his deep understanding of medicinal chemistry and his ability to translate complex scientific concepts into practical applications that address urgent health needs.
Collaborations
Raghavan has also worked alongside notable professionals in the field, such as Joie Garfunkle and Alan Whitehead. These collaborations have likely enriched his research and fostered an environment of innovation, enabling the development of effective therapeutic compounds aimed at improving patient outcomes.
Conclusion
Subharekha Raghavan's contributions to the field of pharmaceutical innovations are noteworthy, particularly his work with PDE9 inhibitors. With a strong portfolio of patents, he exemplifies the spirit of innovation in the pharmaceutical industry. His efforts not only highlight the potential for new medical treatments but also inspire future advancements in the realm of drug development and therapeutic solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.